Allograft rejection: Effect of local synthesis of complement

Springer Seminars in Immunopathology

Volumn 27, Issue 3, 2005, Pages 332-344

  Sacks, Steven H ^a   Zhou, Wuding ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; COMPLEMENT; COMPLEMENT RECEPTOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA;

ALLOIMMUNITY; ANTIGEN SPECIFICITY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; DISEASE ASSOCIATION; EXTRAVASCULAR SPACE; GENE EXPRESSION; GRAFT REJECTION; HUMAN; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; KIDNEY ALLOGRAFT; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INFECTION; KIDNEY TRANSPLANTATION; MICE; REPERFUSION INJURY; TRANSPLANTATION, HOMOLOGOUS;

EID: 27844587233     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-005-0005-0     Document Type: Review

References (103)

1. Alper CA, Johnson AM, Birtch AG, Moore FD (1969) Human C′3: evidence for the liver as the primary site of synthesis. Science 163:286-288
2. Alper CA, Raum D, Awdeh ZL, Petersen BH, Taylor PD, Starzl TE (1980) Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B. Clin Immunol Immunopathol 16:84-89
3. Morris KM, Aden DP, Knowles BB, Colten HR (1982) Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest 70:906-913
4. Morgan BP, Gasque P (1997) Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 107:1-7
5. Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP (2000) Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49:171-186
6. Feucht HE, Zwirner J, Bevec D, Lang M, Felber E, Riethmuller G, Weiss EH (1989) Biosynthesis of complement C4 messenger RNA in normal human kidney. Nephron 53:338-342
7. Passwell JH, Schreiner GF, Wetsel RA, Colten HR (1990) Complement gene expression in hepatic and extrahepatic tissues of NZB and NZBxW (F1) mouse strains. Immunology 71:290-294
8. Song D, Zhou W, Sheerin SH, Sacks SH (1998) Compartmental localization of complement component transcripts in the normal human kidney. Nephron 78:15-22
9. Timmerman JJ, van der Woude FJ, Gijlswijk-Janssen DJ, Verweij CL, van Es LA, Daha MR (1996) Differential expression of complement components in human fetal and adult kidneys. Kidney Int 49:730-740
10. Botto M, Lissandrini D, Sorio C, Walport MJ (1992) Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 149:1348-1355
11. Colten HR, Strunk RC, Perlmutter DH, Cole FS (1986) Regulation of complement protein biosynthesis in mononuclear phagocytes. Ciba Found Symp 118:141-154
12. Sacks SH, Zhou W, Pani A, Campbell RD, Martin J (1993) Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 79:348-354
13. Brooimans RA, van der Ark AA, Buurman WA, van Es LA, Daha MR (1990) Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. J Immunol 144:3835-3840
14. Brooimans RA, Stegmann AP, van Dorp WT, van der Ark AA, van der Woude FJ, van Es LA, Daha MR (1991) Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88:379-384
15. Rothman BL, Despins AW, Kreutzer DL (1990) Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549. J Immunol 145:592-598
16. Falus A, Beuscher HU, Auerbach HS, Colten HR (1987) Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific. J Immunol 138:856-860
17. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
18. Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343:338-344
19. Gordon S (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-930
20. Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL (2000) Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 69:405-410
21. Gasser M, Waaga AM, Laskowski IA, Tilney NL (2000) The influence of donor brain death on short and long-term outcome of solid organ allografts. Ann Transplant 5:61-67
22. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, Matas AJ (1995) Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 59:962-968
23. Chkhotua AB, Klein T, Shabtai E, Yussim A, Bar-Nathan N, Shaharabani E, Lustig S, Mor E (2003) Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Urology 62:1002-1006
24. Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058-1066
25. Walport MJ (2001) Complement. Second of two parts. N Engl J Med 344:1140-1144
26. Mollnes TE, Song WC, Lambris JD (2002) Complement in inflammatory tissue damage and disease. Trends Immunol 23:61-64
27. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-350
28. Arvieux J, Yssel H, Colomb MG (1988) Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65:229-235
29. McPhaden AR, Whaley K (1993) Complement biosynthesis by mononuclear phagocytes. Immunol Res 12:213-232
30. Legoedec J, Gasque P, Jeanne JF, Fontaine M (1995) Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur J Immunol 25:3460-3466
31. Basset-Seguin N, Caughman SW, Yancey KB (1990) A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J Invest Dermatol 95:621-625
32. Choy LN, Rosen BS, Spiegelman BM (1992) Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 267:12736-12741
33. Barnum SR (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132-146
34. Zhao YX, Andoh A, Shimada M, Takaya H, Hata K, Fujiyama Y, Bamda T (2000) Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type II epithelial cell line A549. Int J Mol Med 5:415-419
35. Katz Y, Strunk RC (1988) Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum 31:1365-1370
36. Molmenti EP, Ziambaras T, Perlmutter DH (1993) Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 268:14116-14124
37. Sacks S, Zhou W, Campbell RD, Martin J (1993) C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 93:411-417
38. Sheerin NS, Zhou W, Adler S, Sacks SH (1997) TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int 51:703-710
39. Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545-568
40. Erdei A, Fust G, Gergely J (1991) The role of C3 in the immune response. Immunol Today 12:332-337
41. Mathew M, Bolton WK (1988) Linear C3 deposits on the tubular basement membrane in renal allograft biopsies. Am J Kidney Dis 12:121-125
42. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S (1994) Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46:89-96
43. Welch TR, Beischel LS, Witte DP (1993) Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 92:1451-1458
44. Sasaki O, Zhou W, Miyazaki M, Abe K, Koji T, Verroust P, Tsukasaki S, Ozono Y, Harada T, Nakane PK et al (1997) Intraglomerular C3 synthesis in rats with passive Heymann nephritis. Am J Pathol 151:1249-1256
45. Thurman JM, Lucia MS, Ljubanovic D, Holers VM (2005) Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 67:524-530
46. Sacks SH, Zhou W, Andrews PA, Hartley B (1993) Endogenous complement C3 synthesis in immune complex nephritis. Lancet 342:1273-1274
47. Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH (1999) Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 162:4336-4341
48. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH (2000) Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105:1363-1371
49. Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH (2001) Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 7:801-806
50. Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8:582-587
51. Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH (2000) In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 157:825-831
52. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM (2003) Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170:1517-1523
53. Farrar CA, Wang Y, Sacks SH, Zhou W (2004) Independent pathways of p-selectin and complement-mediated renal ischemia/reperfusion injury. Am J Pathol 164:133-141
54. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM (2003) A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63:134-142
55. de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA (2003) Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170:3883-3889
56. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL (1997) The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 99:2682-2690
57. Vakeva A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S (1994) Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144:1357-1368
58. Vakeva A, Meri S (1998) Complement activation and regulator expression after anoxic injury of human endothelial cells. APMIS 106:1149-1156
59. Andrews PA, Pani A, Zhou W, Sacks SH (1994) Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcome. Transplantation 58:637-640
60. Andrews PA, Finn JE, Lloyd CM, Zhou W, Mathieson PW, Sacks SH (1995) Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 25:1087-1093
61. Dallman MJ, Larsen CP, Morris PJ (1991) Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 174:493-496
62. Gerritsma JS, Gerritsen AF, Van Kooten C, van Es LA, Daha MR (1996) Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Mol Immunol 33:847-854
63. Hong Y, Zhou W, Li K, Sacks SH (2002) Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 62:1291-1300
64. Biancone L, David S, Della PV, Montrucchio G, Cambi V, Camussi G (1994) Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45:451-460
65. David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G (1997) Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12:51-56
66. Yaskanin DD, Waxman FJ (1995) Expression of the CR1 receptor on human leukemia-derived CD4+ T cell lines. Cell Immunol 163:139-147
67. Hess MW, Schwendinger MG, Eskelinen EL, Pfaller K, Pavelka M, Dierich MP, Prodinger WM (2000) Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21). Blood 95:2617-2623
68. Wagner C, Hansch GM, Stegmaier S, Denefleh B, Hug F, Schoels M (2001) The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur J Immunol 31:1173-1180
69. Seya T, Ballard LL, Bora NS, Kumar V, Cui W, Atkinson JP (1988) Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol 18:1289-1294
70. Kinoshita T, Medof ME, Silber R, Nussenzweig V (1985) Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162:75-92
71. Fernandez-Centeno E, de Ojeda G, Rojo JM, Portoles P (2000) Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J Immunol 164:4533-4542
72. Hanna SM, Spiller OB, Linton SM, Mead RJ, Morgan BP (2002) Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement. Eur J Immunol 32:502-509
73. Pepys MB (1972) Role of complement in induction of the allergic response. Nat New Biol 237:157-159
74. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL et al (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157:549-556
75. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251-262
76. Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A 93:3357-3361
77. Marsh JE, Farmer CK, Jurcevic S, Wang Y, Carroll MC, Sacks SH (2001) The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 72:1310-1318
78. Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5:981-986
79. Erdei A, Kohler V, Schafer H, Burger R (1992) Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens. Immunobiology 185:314-326
80. Kerekes K, Prechl J, Bajtay Z, Jozsi M, Erdei A (1998) A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol 10:1923-1930
81. Li K, Patel H, Farrar CA, Hargreaves RE, Sacks SH, Zhou W (2004) Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J Am Soc Nephrol 15:2414-2422
82. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG (1995) Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84:164-170
83. Rey-Millet CA, Chesne S, Colomb MG (1993) Associated complement C3b. Towards an understanding of its intracellular modifications. Mol Immunol 30:855-864
84. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 3:659-666
85. Edwards AD, Chaussabel D, Tomlinson S, Schulz O, Sher A, Reis E Sousa (2003) Relationships among murine CD11c(high) dendritic cell subsets as revealed by baseline gene expression patterns. J Immunol 171:47-60
86. Byrd LH, Tapia L, Cheigh JS, Aronian J, Stenzel KH, Rubin AL (1978) Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation. Lancet 2:1167-1169
87. Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, Barbour G, Lipnick R, Cruess DF (2004) Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 44:353-362
88. Muller V, Becker G, Delfs M, Albrecht KH, Philipp T, Heemann U (1998) Do urinary tract infections trigger chronic kidney transplant rejection in man? J Urol 159:1826-1829
89. Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy JC, Bosshard S, Colon S, Betuel H, Aymard M, Touraine JL (1993) Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 55:851-857
90. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ (1999) Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 68:1879-1883
91. Morelli AE, Thomson AW (2003) Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 196:125-146
92. Pantenburg B, Heinzel F, Das L, Heeger PS, Valujskikh A (2002) T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 169:3686-3693
93. Shimamura T (1981) Mechanisms of renal tissue destruction in an experimental acute pyelonephritis. Exp Mol Pathol 34:34-42
94. Park P, Haas M, Cunningham PN, Alexander JJ, Bao L, Guthridge JM, Kraus DM, Holers VM, Quigg RJ (2001) Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J Am Soc Nephrol 12:1383-1390
95. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146-151
96. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FD Jr (1992) Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 149:1723-1728
97. Pratt JR, Hibbs MJ, Laver AJ, Smith RA, Sacks SH (1996) Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 149:2055-2066
98. Mulligan MS, Warner RL, Rittershaus CW, Thomas LJ, Ryan US, Foreman KE, Crouch LD, Till GO, Ward PA (1999) Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties. J Immunol 162:4952-4959
99. Pratt JR, Jones ME, Dong J, Zhou W, Chowdhury P, Smith RA, Sacks SH (2003) Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 163:1457-1465
100. Zach TL, Hill LD, Herrman VA, Leuschen MP, Hostetter MK (1992) Effect of glucocorticoids on C3 gene expression by the A549 human pulmonary epithelial cell line. J Immunol 148:3964-3969
101. Strunk RC, Tashjian AH Jr, Colten HR (1975) Complement biosynthesis in vitro by rat hepatoma cell strains. J Immunol 114:331-335
102. Lemercier C, Julen N, Coulpier M, Dauchel H, Ozanne D, Fontaine M, Ripoche J (1992) Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/ macrophage lineage. Eur J Immunol 22:909-915
103. Lakkis FG (2002) Transplant rejection: mind your T-cell language. Nat Med 8:1043